Published: August 14, 2018

Dr. Scott Bratman, researcher at Princess Margaret Cancer Centre and CCTG Senior Investigator Wendy Parulekar awarded CIHR grant for HN.10 study

The Canadian Institute of Health Research (CIHR) has announced a project grant award of $860,628 over six years for a research project lead by the Canadian Cancer Trials Group (CCTG). The HN.10 study will investigate the potential benefits of the de-escalation of treatment for patients with tonsil cancer.

Published: June 19, 2018
TAILORx / MAC.12 breast cancer trial showed no benefit from chemotherapy for 70% of women with the most common form of breast cancer.

TAILORx / MAC.12 breast cancer trial showed no benefit from chemotherapy for 70% of women with the most common form of breast cancer.

Clinical trials are not always about finding a new drug that works but sometimes challenge current standards of care that may help spare patients unnecessary treatment.

Published: June 14, 2018

The CCTG TRIALBLAZERS have been training hard for this year’s Kingston Relay for Life, June 22, 2018 - 6:00 pm - 12:00 am.

Published: June 04, 2018

Dr. Jim Biagi, Queen's University Researcher & Oncologist at the Cancer Centre of South Eastern Ontario and the CCTG Canadian study co-chair with clinical trial participant Kathleen Kennedy

Newly released clinical trial results show a substantial increase in survival rates for pancreatic cancer patients who received a four-drug chemotherapy combination known as mFOLFIRINOX after surgery. The randomized phase III clinical trial was sponsored by the academic cancer research groups of UNICANCER, in Paris, France and the Canadian Cancer Trials Group (CCTG). The results show that the risk of cancer recurring in post-operative pancreatic cancer patients was reduced by almost 50% with the mFOLFIRINOX chemotherapy combination.

Published: May 23, 2018

The Sunnybrook Health Sciences Centre and the Ottawa Hospital are currently enrolling women in the Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare conventional mammography (2-D) to the newer digital tomosynthesis method (3-D).

Published: March 28, 2018

Dr. Frances Shepherd, medical oncologist at Princess Margaret Cancer Centre, has received the prestigious 2018 Canada Gairdner Wightman Award "for her global leadership in oncology which has contributed significantly to the improving survival outcome of lung cancer patients worldwide."

Published: March 15, 2018
(left to right) Shakeel Virk, Director Operations & Pathology Coordinator of the CCTG Tumour Tissue Data Repository, Dr David LeBrun, Academic Director, Queen's Laboratory for Molecular Pathology, Ms. Sophie Kiwala, MPP for Kingston and the Islands, Dr Lois Shepherd Director of the CCTG Tumour Tissue Data Repository, Dr. Madhuri Koti, Queen's University (back) Dr. John Fisher, Vice-Principal (Research), Queen’s University.
Published: January 08, 2018
Cancer Research Institute and Canadian Cancer Trials Group Announce Strategic Collaboration

CCTG and CRI collaborate to bring important improvements in cancer therapies to the patients that need them

The Cancer Research Institute (CRI) and the Canadian Cancer Trials Group (CCTG) have announced a multi-year collaboration to develop and conduct clinical trials in immunotherapy.

Published: January 02, 2018
CCTG network researchers have been recognized with the Order of Canada

CCTG network researchers have been recognized by Governor General Julie Payette who announced the Order of Canada appointments on Friday, Dec. 29. Please join us in congratulating Dr. Pritchard, Dr. Gleave and Dr. Eisenhauer on this wonderful honour and for their outstanding contributions to cancer clinical trial research in Canada.

Dr. Elizabeth Eisenhauer, Officer of the Order of Canada

Published: December 05, 2016
CCTG Directors -Dr. Elizabeth Eisenhauer, head of the Queen’s Department of Oncology, Dr. Joe Pater, former CCTG Director, Dr. Janet Dancey, CCTG Director,

Dr. Elizabeth Eisenhauer, head of the Queen’s Department of Oncology, Dr. Joe Pater, former CCTG Director, Dr. Janet Dancey, CCTG Director,

Patients facing a cancer diagnosis invariably have many questions, but one tops the list – what is the best treatment? Answering that question is the compelling goal of medical research that is testing new treatments for similarly-diagnosed patients in carefully monitored and controlled ways. Such studies, known as clinical trials, have been instrumental in altering and improving the way cancer is now approached.